Breaking News Instant updates and real-time market news.

DMTGF

Daily Mail and General Trust

$0.00 /

+ (+0.00%)

12:21
05/29/20
05/29
12:21
05/29/20
12:21

Daily Mail and General Trust price target lowered to 860 GBp at Morgan Stanley

Morgan Stanley analyst Patrick Wellington lowered the firm's price target on Daily Mail and General Trust to 860 GBp from 900 GBp and keeps an Equal Weight rating on the shares.

DMTGF Daily Mail and General Trust
$0.00 /

+ (+0.00%)

05/29/20 JPMorgan
Daily Mail and General Trust price target lowered to 800 GBp at JPMorgan

TODAY'S FREE FLY STORIES

Initiation
Azek initiated with a Buy at SunTrust » 07:34
07/07/20
07/07
07:34
07/07/20
07:34
AZEK

Azek

$31.59 /

-0.945 (-2.91%)

SunTrust analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZEK Azek
$31.59 /

-0.945 (-2.91%)

06:36 Today BofA
Azek initiated with a Neutral at BofA
06:35 Today Stephens
Azek initiated with an Equal Weight at Stephens
06:23 Today Jefferies
Azek initiated with a Buy at Jefferies
06:22 Today RBC Capital
Azek initiated with an Outperform at RBC Capital
  • 12
    Jun
AZEK Azek
$31.59 /

-0.945 (-2.91%)

Hot Stocks
Leidos awarded new task order by the U.S. Army worth up to $210M » 07:34
07/07/20
07/07
07:34
07/07/20
07:34
LDOS

Leidos

$88.33 /

-5.39 (-5.75%)

Leidos announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LDOS Leidos
$88.33 /

-5.39 (-5.75%)

LDOS Leidos
$88.33 /

-5.39 (-5.75%)

06/11/20
Fly Intel: Top five analyst initiations
06/11/20 Baird
Baird starts Leidos at Outperform, sees growth poised to ramp next year
06/10/20 Baird
Leidos initiated with an Outperform at Baird
05/07/20
Fly Intel: Top five analyst initiations
LDOS Leidos
$88.33 /

-5.39 (-5.75%)

LDOS Leidos
$88.33 /

-5.39 (-5.75%)

LDOS Leidos
$88.33 /

-5.39 (-5.75%)

Hot Stocks
Hartford Financial extends COVID-19 personal auto payback plan » 07:33
07/07/20
07/07
07:33
07/07/20
07:33
HIG

Hartford Financial

$38.29 /

+0.81 (+2.16%)

The Hartford is extending…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HIG Hartford Financial
$38.29 /

+0.81 (+2.16%)

HIG Hartford Financial
$38.29 /

+0.81 (+2.16%)

05/05/20 Deutsche Bank
Hartford Financial price target lowered to $53 from $63 at Deutsche Bank
04/14/20 Morgan Stanley
Hartford Financial upgraded to Overweight from Equal Weight at Morgan Stanley
04/08/20 RBC Capital
Hartford Financial price target lowered to $39 from $66 at RBC Capital
04/01/20 Wells Fargo
Hartford Financial upgraded to Overweight from Equal Weight at Wells Fargo
HIG Hartford Financial
$38.29 /

+0.81 (+2.16%)

HIG Hartford Financial
$38.29 /

+0.81 (+2.16%)

HIG Hartford Financial
$38.29 /

+0.81 (+2.16%)

HIG Hartford Financial
$38.29 /

+0.81 (+2.16%)

Hot Stocks
Strongbridge Biopharma appoints John Johnson as CEO » 07:33
07/07/20
07/07
07:33
07/07/20
07:33
SBBP

Strongbridge Biopharma

$3.80 /

+0.13 (+3.54%)

Strongbridge Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBBP Strongbridge Biopharma
$3.80 /

+0.13 (+3.54%)

SBBP Strongbridge Biopharma
$3.80 /

+0.13 (+3.54%)

03/03/20
Fly Intel: Top five analyst initiations
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
09/24/19 Evercore ISI
Strongbridge Biopharma initiated with an Outperform at Evercore ISI
SBBP Strongbridge Biopharma
$3.80 /

+0.13 (+3.54%)

Earnings
Rollins sees Q2 revenue growth 'low to mid-single digits,' consensus $487.52M » 07:32
07/07/20
07/07
07:32
07/07/20
07:32
ROL

Rollins

$42.73 /

-0.29 (-0.67%)

Rollins provided a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROL Rollins
$42.73 /

-0.29 (-0.67%)

ROL Rollins
$42.73 /

-0.29 (-0.67%)

06/05/20 Stifel
Rollins takeout seems unlikely given current valuation, says Stifel
11/21/19 Jefferies
Jefferies initiates Diversifed Services sector
11/21/19 Jefferies
Rollins initiated with a Hold at Jefferies
11/06/19
Fly Intel: Top five analyst upgrades
ROL Rollins
$42.73 /

-0.29 (-0.67%)

ROL Rollins
$42.73 /

-0.29 (-0.67%)

Hot Stocks
Novocure enrolls last patient in HEPANOVA trial » 07:32
07/07/20
07/07
07:32
07/07/20
07:32
NVCR

Novocure

$62.85 /

+2.21 (+3.64%)

Novocure announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVCR Novocure
$62.85 /

+2.21 (+3.64%)

NVCR Novocure
$62.85 /

+2.21 (+3.64%)

07/06/20 Mizuho
Novocure has large growth opportunity in China, says Mizuho
05/20/20 Piper Sandler
Novocure remains top idea in oncology equipment at Piper Sandler
05/13/20 Piper Sandler
Piper says Novocure opens up largest GBM market with China approval
05/01/20 SunTrust
Novocure price target lowered to $90 from $105 at SunTrust
NVCR Novocure
$62.85 /

+2.21 (+3.64%)

NVCR Novocure
$62.85 /

+2.21 (+3.64%)

Recommendations
Electronic Arts price target raised to $150 from $125 at Oppenheimer » 07:31
07/07/20
07/07
07:31
07/07/20
07:31
EA

Electronic Arts

$134.18 /

+0.48 (+0.36%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EA Electronic Arts
$134.18 /

+0.48 (+0.36%)

EA Electronic Arts
$134.18 /

+0.48 (+0.36%)

06/26/20 Needham
Electronic Arts price target raised to $150 from $135 at Needham
06/26/20 BMO Capital
Electronic Arts price target raised to $132 from $110 at BMO Capital
06/26/20 Stephens
Electronic Arts price target raised to $145 from $130 at Stephens
06/23/20 MKM Partners
Electronic Arts price target raised to $144 from $130 at MKM Partners
EA Electronic Arts
$134.18 /

+0.48 (+0.36%)

EA Electronic Arts
$134.18 /

+0.48 (+0.36%)

EA Electronic Arts
$134.18 /

+0.48 (+0.36%)

EA Electronic Arts
$134.18 /

+0.48 (+0.36%)

Hot Stocks
Kirkland Lake Gold sees FY20 gold production 1.35M-1.4M ounces  07:31
07/07/20
07/07
07:31
07/07/20
07:31
KL

Kirkland Lake Gold

$41.92 /

+0.285 (+0.68%)

 
ShowHide Related Items >><<
KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

06/11/20
Fly Intel: Top five analyst upgrades
06/11/20 Roth Capital
Kirkland Lake upgraded to Buy on higher gold prices at Roth Capital
06/11/20 Roth Capital
Kirkland Lake Gold upgraded to Buy from Neutral at Roth Capital
05/29/20 BMO Capital
Kirkland Lake Gold upgraded to Outperform from Market Perform at BMO Capital
KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

Downgrade
Illumina downgraded to Neutral following 81% rise off lows at Guggenheim » 07:31
07/07/20
07/07
07:31
07/07/20
07:31
ILMN

Illumina

$379.26 /

+6.62 (+1.78%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$379.26 /

+6.62 (+1.78%)

ILMN Illumina
$379.26 /

+6.62 (+1.78%)

06:09 Today Guggenheim
Illumina downgraded to Neutral from Buy at Guggenheim
07/02/20 JPMorgan
Illumina price target raised to $390 from $340 at JPMorgan
05/21/20 Argus
Illumina price target raised to $380 from $340 at Argus
05/01/20 Piper Sandler
Illumina price target lowered to $356 from $370 at Piper Sandler
ILMN Illumina
$379.26 /

+6.62 (+1.78%)

ILMN Illumina
$379.26 /

+6.62 (+1.78%)

ILMN Illumina
$379.26 /

+6.62 (+1.78%)

Hot Stocks
Kirkland Lake Gold reports Q2 gold production of 329,770 ounces » 07:29
07/07/20
07/07
07:29
07/07/20
07:29
KL

Kirkland Lake Gold

$41.92 /

+0.285 (+0.68%)

Kirkland Lake Gold…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

06/11/20
Fly Intel: Top five analyst upgrades
06/11/20 Roth Capital
Kirkland Lake upgraded to Buy on higher gold prices at Roth Capital
06/11/20 Roth Capital
Kirkland Lake Gold upgraded to Buy from Neutral at Roth Capital
05/29/20 BMO Capital
Kirkland Lake Gold upgraded to Outperform from Market Perform at BMO Capital
KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

KL Kirkland Lake Gold
$41.92 /

+0.285 (+0.68%)

Downgrade
Guggenheim downgrades Bellus Health to Neutral after 'disappointing' cough trial » 07:26
07/07/20
07/07
07:26
07/07/20
07:26
BLU

Bellus Health

$3.45 /

-8.56 (-71.27%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLU Bellus Health
$3.45 /

-8.56 (-71.27%)

BLU Bellus Health
$3.45 /

-8.56 (-71.27%)

06:12 Today Guggenheim
Bellus Health downgraded to Neutral from Buy at Guggenheim
07/06/20 Jefferies
Jefferies cuts Bellus target to $6, sees potential for 'meaningful upside'
07/06/20 Mackie
Bellus Health downgraded to Hold from Speculative Buy at Mackie
07/06/20 H.C. Wainwright
H.C. Wainwright reiterates $28 target on Bellus despite Phase 2 miss
  • 05
    Sep
BLU Bellus Health
$3.45 /

-8.56 (-71.27%)

Conference/Events
Morgan Stanley semiconductors analysts to hold a webinar » 07:25
07/07/20
07/07
07:25
07/07/20
07:25

Semiconductors Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS mining analysts to hold analyst/industry conference call » 07:25
07/07/20
07/07
07:25
07/07/20
07:25

Mining Analysts discuss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Sangamo initiated with a Buy at SunTrust » 07:24
07/07/20
07/07
07:24
07/07/20
07:24
SGMO

Sangamo

$9.82 /

+0.18 (+1.87%)

, BIIB

Biogen

$269.55 /

+4.2 (+1.58%)

SunTrust analyst Nicole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGMO Sangamo
$9.82 /

+0.18 (+1.87%)

BIIB Biogen
$269.55 /

+4.2 (+1.58%)

SGMO Sangamo
$9.82 /

+0.18 (+1.87%)

06:53 Today SunTrust
Sangamo initiated with a Buy at SunTrust
06/22/20 H.C. Wainwright
Sangamo price target lowered to $14 from $16 at H.C. Wainwright
02/28/20 William Blair
Biogen deal with Sangamo unlikely to have near-term impact, says William Blair
02/03/20 Evercore ISI
Evercore ISI downgrades Crispr Therapeutics, questions relative valuation
BIIB Biogen
$269.55 /

+4.2 (+1.58%)

06/22/20 RBC Capital
Biogen price target lowered to $273 from $303 at RBC Capital
06/22/20 Barclays
Barclays downgrades Biogen to Equal Weight on 'mounting uncertainties'
06/22/20 Barclays
Biogen downgraded to Equal Weight from Overweight at Barclays
06/19/20 Citi
Biogen patent loss a 'major setback,' says Citi
SGMO Sangamo
$9.82 /

+0.18 (+1.87%)

BIIB Biogen
$269.55 /

+4.2 (+1.58%)

BIIB Biogen
$269.55 /

+4.2 (+1.58%)

SGMO Sangamo
$9.82 /

+0.18 (+1.87%)

BIIB Biogen
$269.55 /

+4.2 (+1.58%)

SGMO Sangamo
$9.82 /

+0.18 (+1.87%)

BIIB Biogen
$269.55 /

+4.2 (+1.58%)

Downgrade
Total Access Communications downgraded to Sell from Neutral at Citi » 07:20
07/07/20
07/07
07:20
07/07/20
07:20
TACYY

Total Access Communications

$0.00 /

+ (+0.00%)

Citi analyst Arthur…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TACYY Total Access Communications
$0.00 /

+ (+0.00%)

05/05/20 Goldman Sachs
Total Access downgraded to Sell from Neutral at Goldman Sachs
03/24/20 Goldman Sachs
Total Access Communications upgraded to Neutral from Sell at Goldman Sachs
02/19/20 JPMorgan
Total Access downgraded to Underweight from Overweight at JPMorgan
Hot Stocks
Corvus Pharmaceuticals initiates study to investigate immunotherapy for COVID-19 » 07:19
07/07/20
07/07
07:19
07/07/20
07:19
CRVS

Corvus Pharmaceuticals

$2.76 /

+0.21 (+8.24%)

Corvus Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRVS Corvus Pharmaceuticals
$2.76 /

+0.21 (+8.24%)

CRVS Corvus Pharmaceuticals
$2.76 /

+0.21 (+8.24%)

03/10/20 H.C. Wainwright
Corvus Pharmaceuticals initiated with a Buy at H.C. Wainwright
12/09/19 Mizuho
Corvus pipeline updates 'can only be additive,' says Mizuho
09/12/19 Mizuho
Mizuho starts Corvus Pharmaceuticals with Buy rating, $7 price target
09/11/19 Mizuho
Corvus Pharmaceuticals initiated with a Buy at Mizuho
CRVS Corvus Pharmaceuticals
$2.76 /

+0.21 (+8.24%)

Recommendations
Netflix price target raised to $550 from $465 at Credit Suisse » 07:19
07/07/20
07/07
07:19
07/07/20
07:19
NFLX

Netflix

$494.09 /

+17.78 (+3.73%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$494.09 /

+17.78 (+3.73%)

NFLX Netflix
$494.09 /

+17.78 (+3.73%)

07/06/20
Fly Intel: Top five analyst downgrades
07/06/20 Canaccord
Netflix content leadership poised to persist, says Canaccord
07/06/20 Imperial Capital
Netflix downgraded to In-Line from Outperform at Imperial Capital
07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
NFLX Netflix
$494.09 /

+17.78 (+3.73%)

NFLX Netflix
$494.09 /

+17.78 (+3.73%)

NFLX Netflix
$494.09 /

+17.78 (+3.73%)

NFLX Netflix
$494.09 /

+17.78 (+3.73%)

NFLX Netflix
$494.09 /

+17.78 (+3.73%)

Hot Stocks
Regeneron: REGN-COV2 initial doses may be ready as early as end of summer » 07:17
07/07/20
07/07
07:17
07/07/20
07:17
REGN

Regeneron

$626.65 /

+5.89 (+0.95%)

Regeneron began scaling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$626.65 /

+5.89 (+0.95%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

07/01/20 Oppenheimer
Regeneron price target raised to $675 from $625 at Oppenheimer
06/24/20 Credit Suisse
Regeneron price target raised to $700 from $605 at Credit Suisse
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
06/18/20 Piper Sandler
AbbVie atopic dermatitis data a postive, says Piper Sandler
REGN Regeneron
$626.65 /

+5.89 (+0.95%)

  • 27
    May
REGN Regeneron
$626.65 /

+5.89 (+0.95%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

Downgrade
Benchmark downgrades ACM Research to Hold following 327% year-to-date rally » 07:17
07/07/20
07/07
07:17
07/07/20
07:17
ACMR

ACM Research

$80.87 /

+15.11 (+22.98%)

Benchmark analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACMR ACM Research
$80.87 /

+15.11 (+22.98%)

ACMR ACM Research
$80.87 /

+15.11 (+22.98%)

06:23 Today Benchmark
ACM Research downgraded to Hold from Buy at Benchmark
06/22/20 Stifel
ACM Research downgraded to Hold from Buy at Stifel
05/19/20 Roth Capital
ACM Research price target raised to $80 from $60 at Roth Capital
05/07/20 Stifel
ACM Research price target raised to $50 from $28 at Stifel
ACMR ACM Research
$80.87 /

+15.11 (+22.98%)

  • 15
    Aug
ACMR ACM Research
$80.87 /

+15.11 (+22.98%)

ACMR ACM Research
$80.87 /

+15.11 (+22.98%)

Initiation
Huize initiated with a Buy at Citi » 07:17
07/07/20
07/07
07:17
07/07/20
07:17
HUIZ

Huize

$8.10 /

+0.69 (+9.31%)

Citi analyst Michelle Ma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUIZ Huize
$8.10 /

+0.69 (+9.31%)

  • 12
    Feb
HUIZ Huize
$8.10 /

+0.69 (+9.31%)

Hot Stocks
Tonix Pharmaceuticals announces intent to purchase Massachusetts R&D facility » 07:15
07/07/20
07/07
07:15
07/07/20
07:15
TNXP

Tonix Pharmaceuticals

$0.59 /

-0.01 (-1.67%)

Tonix Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TNXP Tonix Pharmaceuticals
$0.59 /

-0.01 (-1.67%)

TNXP Tonix Pharmaceuticals
$0.59 /

-0.01 (-1.67%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
TNXP Tonix Pharmaceuticals
$0.59 /

-0.01 (-1.67%)

  • 16
    Jul
TNXP Tonix Pharmaceuticals
$0.59 /

-0.01 (-1.67%)

Upgrade
Yokohama upgraded to Buy from Neutral at Citi » 07:15
07/07/20
07/07
07:15
07/07/20
07:15
YORUY

Yokohama

$0.00 /

+ (+0.00%)

Citi analyst Arifumi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Cinedigm initiated with a Speculative Buy at Benchmark » 07:14
07/07/20
07/07
07:14
07/07/20
07:14
CIDM

Cinedigm

$2.07 /

-0.02 (-0.96%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CIDM Cinedigm
$2.07 /

-0.02 (-0.96%)

CIDM Cinedigm
$2.07 /

-0.02 (-0.96%)

06:54 Today Benchmark
Cinedigm initiated with a Speculative Buy at Benchmark
CIDM Cinedigm
$2.07 /

-0.02 (-0.96%)

Recommendations
New Wave could offer a 'bit more' for Sina, says Citi » 07:12
07/07/20
07/07
07:12
07/07/20
07:12
SINA

Sina

$40.54 /

+3.86 (+10.52%)

, WB

Weibo

$39.79 /

+6.1 (+18.11%)

Citi analyst Alicia Yap…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SINA Sina
$40.54 /

+3.86 (+10.52%)

WB Weibo
$39.79 /

+6.1 (+18.11%)

SINA Sina
$40.54 /

+3.86 (+10.52%)

02/27/20 BOCOM
Sina downgraded to Neutral from Buy at BOCOM
12/05/19 Goldman Sachs
Sina downgraded to Neutral from Buy at Goldman Sachs
08/21/19 BOCOM
Sina upgraded to Buy from Neutral at BOCOM
08/05/19 Jefferies
Sina assumed with a Hold at Jefferies
WB Weibo
$39.79 /

+6.1 (+18.11%)

05/20/20 HSBC
Weibo price target lowered to $34.50 from $38 at HSBC
05/06/20 OTR Global
Weibo downgraded to Negative from Mixed at OTR Global
04/22/20 Barclays
Weibo downgraded to Equal Weight from Overweight at Barclays
04/01/20
Weibo participates in a conference call with Benchmark
SINA Sina
$40.54 /

+3.86 (+10.52%)

WB Weibo
$39.79 /

+6.1 (+18.11%)

SINA Sina
$40.54 /

+3.86 (+10.52%)

WB Weibo
$39.79 /

+6.1 (+18.11%)

WB Weibo
$39.79 /

+6.1 (+18.11%)

WB Weibo
$39.79 /

+6.1 (+18.11%)

Hot Stocks
Myriad Genetics announces publication of two riskScore analyses » 07:11
07/07/20
07/07
07:11
07/07/20
07:11
MYGN

Myriad Genetics

$11.85 /

+0.325 (+2.82%)

Myriad Genetics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MYGN Myriad Genetics
$11.85 /

+0.325 (+2.82%)

MYGN Myriad Genetics
$11.85 /

+0.325 (+2.82%)

06/11/20 Piper Sandler
Palmetto coverage language unclear about Myriad's GeneSight, says Piper Sandler
05/06/20 JPMorgan
Myriad Genetics price target lowered to $12 from $14 at JPMorgan
05/06/20 Piper Sandler
Myriad Genetics price target lowered to $14 from $20 at Piper Sandler
03/06/20 JPMorgan
Myriad Genetics price target lowered to $14 from $17 at JPMorgan
MYGN Myriad Genetics
$11.85 /

+0.325 (+2.82%)

MYGN Myriad Genetics
$11.85 /

+0.325 (+2.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.